跳至主要内容
临床试验/NCT04409275
NCT04409275Unknown不适用

STUDY OF THE APPEARANCE OF LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION

Fundación para la Investigación del Hospital Clínico de Valencia1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2020年5月21日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
500
试验地点
1
主要终点
Pulmonary fibrotic changes, short and medium term

研究概览

简要总结

Prospective, observational, multicenter study that will evaluate the changes in lung function that patients admitted with SARS-CoV-2 pneumonia will present according to the level of severity at 4, 12, 26 and 52 weeks after hospital discharge.

详细描述

The project consists of a prospective, observational, multicenter study that will evaluate changes in lung function (forced spirometry, measurement of static lung volumes using plethysmography and pulmonary carbon monoxide diffusion test) that patients admitted with pneumonia will present. caused by SARS-CoV-2 according to the level of severity at 4, 12, 26 and 52 weeks after discharge from hospital. Restrictive pulmonary abnormalities will be confirmed by imaging tests (high resolution chest CT).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients admitted for bilateral pneumonia caused by SARS-CoV-2 (confirmed by PCR).
  • Age over 18 years.
  • Acceptance of informed consent.
  • Life expectancy over 1 year.

排除标准

  • Patients with a previous diagnosis of interstitial lung disease.
  • Inability to attend review visits.

结局指标

主要结局

Pulmonary fibrotic changes, short and medium term

时间窗: 12 months

To analyze the number of patients who will develop pulmonary fibrotic changes, in the short and medium term, after surviving a bilateral pulmonary infection by SARS-CoV-2

Degree of lung function impairment

时间窗: 6 and 12 months

To study the degree of lung function impairment, specifically the restrictive changes in functional capacity and diffusion alterations and its relationship with clinical variables.

Biological markers

时间窗: 1 month

Examine the biological markers in the patients who will present this dysregulation of the curative response that will give rise to pulmonary fibrosing phenomena.

次要结局

未报告次要终点

研究者

发起方
Fundación para la Investigación del Hospital Clínico de Valencia
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验